文献速递消化内镜消化道肿瘤与早癌

内镜黏膜下剥离术后同日出院的安全性与可行性:一项西方多中心前瞻性队列研究

Safety and feasibility of same-day discharge after endoscopic submucosal dissection: a Western multicenter prospective cohort study.
PubMed 文献 · Gastrointest Endosc · 2023-01-30

该研究为多中心前瞻性队列的事后分析,纳入2016至2021年接受内镜黏膜下剥离术的831例患者共831例次操作,其中588例(71%)同日出院,243例(29%)收住院;同日出院者迟发出血和穿孔分别发生12例(2%)和4例(0.7%),仅1例(0.2%)需手术;结论认为同日出院安全可行,浸润癌、上消化道病变、手术时间较长及低手术量内镜医师操作者更可能收住院。

要点

  • 831例次内镜黏膜下剥离术中588例(71%)同日出院,243例(29%)收住院。
  • 同日出院者迟发出血12例(2%)、穿孔4例(0.7%),仅1例(0.2%)需手术。
  • 浸润癌、上消化道病变、手术时间>75分钟及低手术量医师操作与收住院相关。

核心结论

  • 内镜黏膜下剥离术后同日出院可安全可行。
  • 浸润癌、上消化道病变、手术时间较长或由低手术量内镜医师操作的患者更可能术后收住院。
  • 作者认为对同日出院患者进行风险分层应有助于优化资源利用并提升西方内镜黏膜下剥离术的开展。

研究设计与样本

  • 多中心前瞻性队列的事后分析,纳入2016至2021年接受内镜黏膜下剥离术的患者。
  • 共831例患者接受831例次内镜黏膜下剥离术。
  • 主要终点为同日出院的安全性和术后收住院的相关因素。
  • 临床试验注册号:NCT02989818。

主要发现

  • 831例次操作中588例(71%)同日出院,243例(29%)收住院。
  • 同日出院患者中迟发出血12例(2%)、穿孔4例(0.7%),仅1例(0.2%)需手术。
  • 243例收住院患者中223例(92%)观察≤24小时后出院。
  • 病变大小>44 mm与收住院率升高无关(OR 0.5;95%CI 0.3-0.8;P=0.001)。
  • 上消化道病变对比结肠病变(OR 1.7;95%CI 1.1-2.6;P=0.01)、浸润癌(OR 1.9;95%CI 1.2-3.1;P=0.01)及不良事件(OR 2.7;95%CI 1.5-4.8;P=0.001)为收住院的独立因素。

关键数值与推荐

  • 同日出院患者迟发出血12例(2%)、穿孔4例(0.7%),需手术1例(0.2%)。
  • 收住院患者中223例(92%)观察≤24小时后出院。
  • 病变大小>44 mm与收住院率升高无关(OR 0.5;95%CI 0.3-0.8;P=0.001)。
  • 上消化道病变对比结肠病变收住院OR 1.7(95%CI 1.1-2.6;P=0.01)。
  • 浸润癌收住院OR 1.9(95%CI 1.2-3.1;P=0.01),不良事件收住院OR 2.7(95%CI 1.5-4.8;P=0.001)。

临床怎么用

  • 原文未据此给出临床推荐,仅报告内镜黏膜下剥离术后同日出院可安全可行。
  • 作者认为对同日出院患者进行风险分层应有助于优化资源利用并提升西方内镜黏膜下剥离术的开展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Recent Western studies support the safety and efficacy of endoscopic submucosal dissection (ESD) for lesions throughout the GI tract. Although admission for observation after ESD is standard in Asia, a more selective approach may optimize resource utilization. We aimed to evaluate the safety and feasibility of same-day discharge (SDD) after ESD and factors associated with admission. METHODS: This was a post hoc analysis of a multicenter, prospective cohort of patients undergoing ESD (2016-2021). The primary end points were safety of SDD and factors associated with post-ESD admission. RESULTS: Of 831 patients (median age, 67 years; 57% male) undergoing 831 ESDs (240 performed in the esophagus, 126 in the stomach, and 465 in the colorectum; median lesion size, 44 mm), 588 (71%) were SDD versus 243 (29%) admissions. Delayed bleeding and perforation occurred in 12 (2%) and 4 (.7%) of SDD patients, respectively; only 1 (.2%) required surgery. Of the 243 admissions, 223 (92%) were discharged after ≤24 hours of observation. Interestingly, larger lesion size (>44 mm) was not associated with higher admission rate (odds ratio [OR], .5; 95% confidence interval [CI], .3-.8; P = .001). Lesions in the upper GI tract versus colon (OR, 1.7; 95% CI, 1.1-2.6; P = .01), invasive cancer (OR, 1.9; 95% CI, 1.2-3.1; P = .01), and adverse events (OR, 2.7; 95% CI, 1.5-4.8; P = .001) were independent factors for admission. Admissions were more likely performed by endoscopists with ESD volume <50 cases (OR, 2.1; 95% CI, 1.3-3.3; P = .001) with procedure time >75 minutes (OR, 13.5; 95% CI, 8.5-21.3; P < .0001). CONCLUSIONS: SDD after ESD can be safe and feasible. Patients with invasive cancer, lesions in the upper GI tract, longer procedure times, or procedures performed by low-volume ESD endoscopists are more likely to be admitted postprocedure. Risk stratification of patients for SDD after ESD should help optimize resource utilization and enhance ESD uptake in the West. (Clinical trial registration number: NCT02989818.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. King W, Draganov P, Gorrepati VS, et al. Safety and feasibility of same-day discharge after endoscopic submucosal dissection: a Western multicenter prospective cohort study. Gastrointest Endosc. 2023. PMID: 36731578. doi:10.1016/j.gie.2023.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。